Association of thyroid disease and thyroid autoimmunity with multiple myeloma risk: A case-control study

Leukemia and Lymphoma

Volumn 49, Issue 8, 2008, Pages 1545-1552

  Dalamaga, Maria ^a   Karmaniolas, Konstantinos ^b   Papadavid, Evangelia ^a   Pelecanos, Nicolaos ^a   Migdalis, Ilias ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NIMTS HOSPITAL   (Greece)

Author keywords

Autoimmunity; Family history; Hematopoiesis; Immunobiology; Multiple myeloma; Neoplasia; Thyroid; Thyrotropin

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; BLOOD SAMPLING; BODY MASS; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ECHOGRAPHY; FAMILY HISTORY; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PLASMA CELL; PREVALENCE; PRIORITY JOURNAL; THYROID DISEASE;

AGED; AUTOIMMUNITY; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; FAMILY HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; ODDS RATIO; RISK FACTORS; THYROID DISEASES;

EID: 51349163641     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802165946     Document Type: Article

References (43)

1. Foerster, J. and Paraskevas, F. (1998) Multiple myeloma. Wintrobe's Clinical Hematology, pp. 2631-2655. Lippincott Williams & Wilkins, Baltimore
2. Kyle, R. A. and Rajkumar, S. V. (2004) Multiple myeloma. N Engl J Med, 351, pp. 1860-1873.
3. Parkin, D. M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J Clin, 55, pp. 74-108.
4. Gramenzi, A., Buttino, I., D'Avanzo, B., Negri, E., Franceschi, S. and La Vecchia, C. (1991) Medical history and the risk of multiple myeloma. Br J Cancer, 63, pp. 769-772.
5. Lewis, D. R., Pottern, L. M., Brown, L. M., Silverman, D. T., Hayes, R. B. Schoenberg, J. B. et al. (1994) Multiple myeloma among blacks and whites in the United States: The role of chronic antigenic stimulation. Cancer Causes Control, 5, pp. 529-539.
6. Alexander, D. D., Mink, P. J., Adami, H. O., Cole, P., Mandel, J. S. Oken, M. M. et al. (2007) Multiple myeloma: A review of the epidemiologic literature. Int J Cancer, 120, pp. 40-61.
7. Morgan, G. J., Davies, F. E. and Linet, M. (2002) Myeloma aetiology and epidemiology. Biomed Pharmacother, 56, pp. 223-234.
8. Cuzick, J. (1981) Radiation-induced myelomatosis. N Engl J Med, 304, p. 204.
9. Blair, C. K., Cerhan, J. R., Folsom, A. R. and Ross, J. A. (2005) Anthropometric characteristics and risk of multiple myeloma. Epidemiology, 16, pp. 691-694.
10. Birmann, B. M., Giovanucci, E., Rosner, B., Andesrson, K. C. and Colditz, G. A. (2007) Body mass index, physical activity and risk of multiple myeloma. Cancer Epidemiol Biomarkers Prev, 16, pp. 1474-1478.
11. Chiu, B. C., Gapstur, S. M., Greenland, P., Wang, R. and Dyer, A. (2006) Body mass index, abnormal glucose metabolism and mortality from hematopoietic cancer. Cancer Epidemiol Biomarkers Prev, 15, pp. 2348-2354.
12. Larsson, S. C. and Wolk, A. (2007) Body mass index and risk of multiple myeloma: A meta-analysis. Int J Cancer, 121, pp. 2512-2516.
13. Lea, A. J. (1964) An association between the rheumatic diseases and the reticuloses. Ann Rheum Dis, 23, pp. 480-484.
14. Bourguet, C. C. and Logue, E. E. (1993) Antigenic stimulation and multiple myeloma. A prospective study. Cancer, 72, pp. 2148-2154.
15. Cuzick, J. and De Stavola, B. L. (1989) Autoimmune disorders and multiple myeloma. Int J Epidemiol, 18, p. 283.
16. Linet, M. S., Harlow, S. D. and McLaughlin, J. K. (1987) A case-control study of multiple myeloma in whites: Antigenic stimulation, occupation and drug use. Cancer Res, 47, pp. 2978-2981.
17. Cohen, H. J., Bernstein, R. J. and Grufferman, S. (1987) Role of immune stimulation in the etiology of multiple myeloma: A case-control study. Am J Hematol, 24, pp. 119-126.
18. Landgren, O., Linet, M. S., McMaster, M. L., Gridley, G., Hemminki, K. and Goldin, L. R. (2006) Familial characteristics and hematologic disorders in 8,406 multiple myeloma patients: A population-based case-control study. Int J Cancer, 118, pp. 3095-3098.
19. Brown, L. M., Gridley, G., Check, D. and Landgren, O. (2008) Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood, 111, pp. 3388-3394.
20. Eriksson, M. (1993) Rheumatoid arthritis as a risk factor for multiple myeloma: A case-control study. Eur J Cancer, 29, pp. 259-263.
21. Isomaki, H. A., Hakulinen, T. and Joutsenlahti, U. (1978) Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chron Dis, 31, pp. 691-696.
22. Saenger, E. L., Thomas, G. E. and Tompkins, E. A. (1968) Incidence of leukemia following treatment of hyperthyroidism. JAMA, 205, p. 855.
23. Moskowitz, C., Dutcher, J. P. and Wiernik, P. H. (1992) Association of thyroid disease with acute leukemia. Am J Hematol, 39, pp. 102-107.
24. Goldman, M. B., Monson, R. R. and Maloof, F. (1990) Cancer mortality in women with thyroid disease. Cancer Res, 50, p. 2283.
25. Dalamaga, M., Lekka, A., Karmaniolas, K., Stathopoulou, E. and Dionyssiou-Asteriou, A. Is thyroid autoimmunity a risk factor for developing primary myelodysplastic syndrome?. Cancer Causes Control 2007
26. Durie, B GM (1986) Staging and kinetics of multiple myeloma. Semin Oncol, 13, pp. 300-309.
27. Durie, B GM and Salmon, S. E. (1975) A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, pp. 842-854.
28. Aghini-Lombardi, F., Pinchera, A., Antonangeli, L., Ragho, T., Fenzi, G. F. Nanni, P. et al. (1993) Iodized salt prophylaxis of endemic goiter: an experience in Toscana (Italy). Acta Endocrinologica, 129, pp. 497-500.
29. Marcocci, C., Vitti, P., Cetani, F., Catalano, F., Concetti, R. and Pinchera, A. (1991) Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrin Metab, 72, pp. 209-213.
30. Breslow, N. E. and Day, N. E. (1980) The analysis of case-control studies. Statistical methods in cancer research, 1, International Agency for Research on Cancer, IARC Scientific Publications, Lyon, France
31. SAS Institute Inc. (1989) SAS/STAT User's Guide, SAS Institute, Cary, NC
32. Kovacs, C. S., Mant, M. J., Nguyen, G. K. and Ginsberg, J. (1994) Plasma cell lesions of the thyroid: Report of a case of solitary plasmacytoma and a review of the literature. Thyroid, 4, pp. 65-71.
33. Wu, M. J., Fang, H. C., Chang, T. Y., Lo, Y. S. and Chung, H. M. (2002) Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis. J Formos Med Assoc, 101, pp. 421-424.
34. Habashi, H. M., Sharp, R. A. and Pippard, M. J. (1991) Multiple myeloma and chronic myelomonocytic leukemia developing in a patient with autoimmune disease. J Intern Med, 230, pp. 361-362.
35. Lindsay, S. and Dailey, M. E. (1955) Malignant lymphoma of the thyroid gland and its relation to Hashimoto disease: A clinical and pathologic study of 8 patients. J Clin Endocrinol Metabol, 15, pp. 1332-1353.
36. Holm, L-E, Blomgren, H. and Lowhagen, T. (1985) Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med, 312, pp. 601-604.
37. Fukuda, A., Hirohata, T., Noguchi, S., Ikeda, M., Matsuo, K. and Yoshida, A. (1987) Risks for malignancies in patients with chronic thyroiditis: A long-term follow-up study. Jpn J Cancer Res, 78, pp. 1329-1334.
38. Talal, N. and Bunim, J. J. (1964) The development of malignant lymphoma in the course of Sjogren's syndrome. Am J Med, 36, pp. 529-540.
39. Drugarin, D., Negru, S., Koreck, A., Zosin, I. and Cristea, C. (2000) The pattern of a TH1 cytokine in autoimmune thyroiditis. Immunol Lett, 71, pp. 73-77.
40. Taddei, S., Caraccio, N., Virdis, A., Dardano, A., Versari, D. Ghiadoni, L. et al. (2006) Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab, 91, pp. 5076-5082.
41. Perillat-Menegaux, F., Clavel, J. Auclerc, M. F. et al. (2003) Family history of autoimmune thyroid disease and childhood leukemia. Cancer Epidemiol Biomed Prev, 12, pp. 60-63.
42. Bernal, J. and Andersson, L. C. (1984) The nuclear 3,5,3[prime]-triiodothyronine receptor in human leukaemic cell lines. Acta Endocrinol (Copenh), 105, pp. 429-432.
43. Hrycek, A. and Gruszka, A. (2006) Thyroid hormone and insulin-like growth factor-I in patients with multiple myeloma treated with melphalan and prednisone. Arch Med Res, 37, pp. 74-78.